Orchid Pharma Ltd share price logo

Orchid Pharma Ltd

NSE: ORCHPHARMA

BSE: 524372

Small Cap

Pharma Sector

₹865.00

+29.65

(+3.55%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Orchid Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-47%

Searches for Orchid Pharma on INDmoney have decreased by 47% over the last 30 days.

Average holding period of indmoney investors

11 days

INDmoney investors hold Orchid Pharma shares for an average of 11 days.

Key Events for Orchid Pharma

Last Dividend Declared

₹3.00 per share, declared on 15/05/2012

View Dividend History

Orchid Pharma Stock Performance

as on October 28, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹833.25
    ₹877.35
    downward going graph

    3.67%

    Downside

    1.43%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹480.00
    ₹1,143.50
    downward going graph

    44.51%

    Downside

    32.20%

    Upside

    downward going graph

Orchid Pharma share price movements today

Previous Close
₹835.35
Open
₹835.00
Volume
48.70K
Upper Circuit
₹1,002.40
Lower Circuit
₹668.30
Day's Low - High
₹833.25 - ₹877.35
52 Week Low - High
₹480.00 - ₹1,143.50

Orchid Pharma Historical Returns

1 Month Return
-17.69 %
3 Month Return
-16.59 %
1 Year Return
+ 17.01 %
3 Year Return
+ 80.09 %
5 Year Return
+ 109.7 %

Orchid Pharma Fundamentals

as on October 28, 2026 at 4:01 pm IST

Market Cap

₹5,002.51 Cr

Return on Equity (ROE)

1.49

PE Ratio (TTM)

679.15

Return on capital employed (ROCE)

1.68

Industry PE ratio

49.78

Beta (LTM)

1.01

P/B Ratio

0.46

Dividend Yield

0

PEG Ratio

-58.1

Quarterly Earnings Growth YOY

-137.45

EPS (TTM)

6.94

Book Value

993.34

Orchid Pharma Stock Valuation

as on October 28, 2026 at 4:01 pm IST

Orchid Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-4674.41x)

January 2, 2026

Industry (49.78x)

October 27, 2026

Today (679.15x)

October 27, 2026

Highest (900.16x)

September 22, 2026

LowHigh

Today’s Price to Earnings Ratio: 679.15x

Orchid Pharma Technical Analysis

Track how Orchid Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish1
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.72
Bearish
CCI (20)
-419.43
Bullish
RSI (14)
40.23
Neutral
Momentum (10)
-1.25
Bearish
ADI (14)
32.57
Bearish
Ultimate Oscillator (7,14,28)
66.13
Neutral

Moving Averages

Name

Value

Action

SMA (20)
865.07
Bearish
EMA (20)
865.02
Bearish
VWMA (20)
864.69
Bearish
SMA (50)
866.28
Bearish
EMA (50)
865.96
Bearish
SMA (200)
869.52
Bearish
EMA (200)
866.55
Bearish
KAMA (200)
866.41
Bearish
DEMA (200)
870.28
Bearish

Orchid Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Orchid Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Orchid Pharma Ltd image
Orchid Pharma Ltd
HOLD5,002.5121.94%0.58101,232
Unichem Laboratories Ltd image
Unichem Laboratories Ltd
NA3,387.2220.12%0.582522,201
Remus Pharmaceuticals Ltd image
Remus Pharmaceuticals Ltd
NA1,037.5258.4%0.5846853
Lasa Supergenerics Ltd image
Lasa Supergenerics Ltd
NA23.40-18.52%0.00-3525
Sotac Pharmaceuticals Ltd image
Sotac Pharmaceuticals Ltd
NA106.63-4.02%0.716101
See all

Market expectation of Orchid Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Orchid Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
220.59
217.1
244.41
222.7
217.34
237.48
263.19
193.52
207.27
368.33
304.17
Other Income
7.62
13.36
7.57
7.52
8.49
3.9
11.57
10.77
5.61
7.77
1.83
Total Income
228.21
230.46
251.98
230.22
225.83
241.38
274.76
204.3
212.88
376.1
306
Expenses
185.2
188.18
211.91
192.36
190.98
209.5
268.83
195
212.82
338.39
290.17
Operating Profit
35.39
28.92
32.5
30.34
26.36
27.98
-5.64
-1.48
-5.55
29.94
14
Operating Profit Margin %
16.04%
13.32%
13.3%
13.62%
12.13%
11.78%
-2.14%
-0.76%
-2.68%
8.13%
4.6%
Profit Before Interest, Tax and Depreciation
43.01
42.28
40.06
37.85
34.85
31.88
5.93
9.3
0.06
37.71
15.83
Interest
3.54
3.47
3.5
3.33
3.8
3.92
2.28
3.73
3.18
1.96
2.23
Depreciation
9.27
8.42
8.44
8.63
8.61
8.87
10.53
8.9
9.03
10.9
10.95
Profit Before Tax
30.2
30.39
28.12
25.89
22.44
19.09
-6.88
-3.33
-12.15
24.85
2.65
Tax Paid
-
-3.12
-0.15
-
-
-0.04
-
-
-
-
0.07
Profit After Tax
30.19
33.5
28.27
25.9
22.45
19.13
-6.89
-3.33
-12.15
24.84
2.58
Total Net profit including share of profit / Loss from associate company
29.43
32.95
29.35
27.24
20.78
22.29
-5.69
-5.72
-12.62
25.84
3.23
EPS
6.18
6.81
5.79
5.37
4.1
4.4
-0.95
-1.13
-2.49
4.31
0.54
Actual EPS
6.18
6.81
5.79
5.37
4.1
4.4
-0.95
-1.13
-2.49
4.31
0.54
Adjusted EPS
6.18
6.81
5.79
5.37
4.1
4.4
-0.95
-1.13
-2.49
4.31
0.54
Diluted EPS
6.18
6.81
5.79
5.37
4.1
4.4
-0.95
-1.13
-2.49
4.31
0.54

Orchid Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
682.98
599.98
483.81
450.06
559.56
665.9
819.37
921.93
1,232.78
Other Income
20.3
217.86
24.28
15.23
67.47
58.64
30.86
27.47
36.42
Total Income
703.29
817.84
508.09
465.29
627.03
724.54
850.23
949.4
1,269.2
Expenses
667.29
618.19
517.03
421.56
506.42
589.06
708.69
804.75
1,206.54
Operating Profit
15.69
-18.21
-33.22
28.5
53.14
76.84
110.68
117.18
26.24
Operating Profit Margin %
2.3%
-3.04%
-6.87%
6.33%
9.5%
11.54%
13.51%
12.71%
2.13%
Profit Before Interest, Tax and Depreciation
36
199.65
-8.94
43.72
120.61
135.48
141.54
144.65
62.66
Interest
301.65
0.3
4.16
51.34
32.01
32.23
16.35
14.54
8.98
Depreciation
133.31
129.94
117.93
108.92
87.02
54.79
33.24
34.55
43.25
Profit Before Tax
-398.96
69.41
-131.03
-116.54
1.58
48.46
91.95
95.56
10.43
Tax Paid
-46.19
-
-
-
-
-
-3.12
-0.19
-0.19
Profit After Tax
-352.77
69.41
-131.03
-116.53
1.57
48.47
95.06
95.76
10.62
Total Net profit including share of profit / Loss from associate company
-352.77
69.41
-131.03
-116.53
-1.95
46.32
92.16
99.66
9.96
EPS
-39.65
7.8
-32.11
-28.55
-0.48
11.35
19.06
19.65
1.66
Actual EPS
-39.65
7.8
-32.11
-28.55
-0.48
11.35
19.06
19.65
1.66
Adjusted EPS
-39.65
7.8
-32.11
-28.55
-0.48
11.35
19.06
19.65
1.66
Diluted EPS
-39.65
7.8
-32.11
-28.55
-0.48
11.35
19.06
19.65
1.66

Orchid Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
212.2
400.95
9.18
12.02
80.8
23.59
92.47
18.34
125.99
51.37
125.64
Cash Flow from Investing Activities
-1.46
-175.95
-28.05
45.47
167.12
67.21
112.94
-31.2
-312.03
-36.48
-276.88
Cash Flow from Financing Activities
-286.36
-465.19
33.39
-0.3
-250.34
-164.99
-216.8
31.16
167.03
2.46
137.13
Net Cash Flow
-75.62
-240.19
14.51
57.2
-2.42
-74.2
-11.39
18.29
-19
17.34
-14.1

Orchid Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
74.45%
DII
14.5%
17.73%
18.93%
18.29%
18.99%
20.1%
19.43%
19.04%
19.39%
20.25%
20.75%
17.44%
FII
4.14%
1.96%
1.42%
1.94%
2.53%
2.69%
1.4%
1.56%
1.17%
0.87%
0.81%
0.93%
Public
11.53%
10.47%
9.81%
9.93%
8.64%
7.38%
9.34%
9.57%
9.6%
9.05%
8.61%
7.18%
Total Outstanding Shares
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,98,85,200
Total Shareholders
36,931
36,720
34,695
36,363
34,158
34,303
39,827
38,155
35,709
35,118
33,433
33,790

Mutual Funds Buying / Exiting Orchid Pharma

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Orchid Pharma

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Orchid Pharma

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

UTI Value fund Fund-Direct Growth Option

UTI Value fund Fund-Direct Growth Option

₹102.84 Cr

₹1.08 Cr (-1.03%)

1.31%

Orchid Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Orchid Pharma.

  • Orchid Pharma Ltd Earnings Results

    Orchid Pharma Ltd’s net profit jumped 156.59% since last year same period to ₹3.22Cr in the Q1 2026-2027. On a quarterly growth basis, Orchid Pharma Ltd has generated -87.54% fall in its net profits since last 3-months.

    Read More

  • Orchid Pharma Ltd Dividends May,2012

    In the quarter ending March 2012, Orchid Pharma Ltd has declared dividend of ₹3.00 per share on 15 May 2012 - translating a dividend yield of 0.72%.

    Read More about Dividends

Indices Featuring Orchid Pharma Stock

Check stock indices that include Orchid Pharma.

BSE Healthcare

₹49,431.85

+522.02 (▲1.07%)

Insights on Orchid Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 69.84% to 74.45% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.80% to 0.92% in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Divis Laboratories Ltd has given 179.3% return, outperforming this stock by 99.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.0% return, outperforming this stock by 29.0%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 19.93% to 16.88% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.61% to 7.18% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 25.84 Cr → 3.22 Cr (in ₹), with an average decrease of 87.5% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 376.1 Cr → 306.0 Cr (in ₹), with an average decrease of 18.6% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ORCHPHARMA stock has moved down by -17.7%

About Orchid Pharma Ltd

Orchid Pharma Ltd. is a globally recognized pharmaceutical company based in Chennai, India, specialized in the development, manufacture and marketing of diverse bulk actives formulations and nutraceuticals. The company’s core expertise covers manufacturing Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms, as well as drug discovery. It is the youngest Indian pharmaceutical company to be awarded the ISO 9002 certification.In 1998 they received approval from the Drug Controller of India (DCI) for the manufacture and export of the main ingredient of Viagra.By 2000 they acquired a manufacturing plant in Aurangabad and in 2004 signed a pact with Par Pharmaceuticals Inc. to market oral cephalosporin formulations in the US market.In 2006 a deal with Biovitrum was signed and two years later the company had approval from the US FDA for their abbreviated new drug application. They entered the Japanese generics market with the creation of awholly owned subsidiary and also inked an agreement with Merck & Co. The company increased their stake in Diakron Pharmaceuticals Inc. up to 76.4 and over the years have made pacts with numerous companies in both drug discovery and commercialization. In 2017 they launched a new product and as of 2020 became a subsidiary of Dhanuka Laboratories Ltd with funding from a special purpose vehicle. Furthermore the company has subscribed to OrBion Pharmaceuticals Pvt. Ltd. and incorporated Orchid BioPharma Ltd, becoming an Associate of the company.

Revenue: ₹304.17Cr as on June 2026 (Q1 FY27)
Net Profit: ₹2.58Cr as on June 2026 (Q1 FY27)
Listing date: 12 May, 1995
Chairperson Name: Ram Gopal Agarwal
OrganisationOrchid Pharma Ltd
IndustryPharmaceuticals
CEORam Gopal Agarwal
E-voting on sharesClick here to vote

FAQs

What is Orchid Pharma share price today?

Orchid Pharma share price today stands at ₹865 as on at the close of the market. Orchid Pharma share today touched a day high of ₹877.35 and a low of ₹833.25.

What is the 52 week high and 52 week low range for Orchid Pharma share?

Orchid Pharma touched a 52 week high of ₹1143.5 and a 52 week low of ₹480. Orchid Pharma share price today i.e. is closed at ₹865, which is -24.36% down from its 52 week high and 80.21% up from its 52 week low.

What is Orchid Pharma's market capitalisation today?

Orchid Pharma market capitalisation is ₹5,002.51 Cr as on .

How to buy Orchid Pharma shares?

To buy Orchid Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ORCHPHARMA or Orchid Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Orchid Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Orchid Pharma trading volume today?

Orchid Pharma trading volume is 48.70K as on . This means that 48.70K shares of Orchid Pharma were bought and sold on the stock market during today's trading session.